Current Heart Failure Reports

, Volume 2, Issue 4, pp 183–188

Cardiac imaging to identify patients at risk for developing heart failure after myocardial infarction

  • Clerio F. Azevedo
  • Susan Cheng
  • João A. C. Lima
Article

Abstract

The development of heart failure (HF) after acute myocardial infarction (MI) is recognized as a major complication that leads to a significant increase in morbidity and mortality. Given the availability of effective treatments for improving both quality of life and survival for patients at increased risk for developing HF after MI, early identification of these individuals is critical. Noninvasive cardiac imaging offers a detailed characterization of two important pathophysiological processes related to the development of HF post-MI: left ventricular (LV) remodeling and LV functional recovery. Cardiovascular MRI has recently emerged as the preferred noninvasive imaging modality because of its ability to provide the most comprehensive and informative evaluation of these processes. In addition to allowing for an accurate and reproducible longitudinal follow-up of LV volumes and mass, MRI also offers information on infarct size, the presence of microvascular obstruction, and the transmural extent of infarct scar, all of which are valuable parameters that can assist in identifying patients at risk for developing HF after MI.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Spencer FA, Meyer TE, Goldberg RJ, et al.: Twenty year trends (1975–1995) in the incidence, in-hospital and long-term death rates associated with heart failure complicating acute myocardial infarction: a community-wide perspective. J Am Coll Cardiol 1999, 34:1378–1387.PubMedCrossRefGoogle Scholar
  2. 2.
    Wu AH, Parsons L, Every NR, Bates ER: Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol 2002, 40:1389–1394.PubMedCrossRefGoogle Scholar
  3. 3.
    Kober L, Torp-Pedersen C, Carlsen JE, et al.: A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. N Engl J Med 1995, 333:1670–1676.PubMedCrossRefGoogle Scholar
  4. 4.
    Kober L, Torp-Pedersen C, Jorgensen S, et al.: Changes in absolute and relative importance in the prognostic value of left ventricular systolic function and congestive heart failure after acute myocardial infarction. TRACE Study Group. Trandolapril Cardiac Evaluation. Am J Cardiol 1998, 81:1292–1297.PubMedCrossRefGoogle Scholar
  5. 5.
    Dargie HJ: Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet 2001, 357:1385–1390.PubMedCrossRefGoogle Scholar
  6. 6.
    Pfeffer MA, Braunwald E, Moye LA, et al.: Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. The SAVE Investigators. N Engl J Med 1992, 327:669–677.PubMedCrossRefGoogle Scholar
  7. 7.
    Weisman HF, Bush DE, Mannisi JA, et al.: Cellular mechanisms of myocardial infarct expansion. Circulation 1988, 78:186–201.PubMedGoogle Scholar
  8. 8.
    Pfeffer MA, Braunwald E: Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990, 81:1161–1172.PubMedGoogle Scholar
  9. 9.
    Weiss JL, Bulkley BH, Hutchins GM, Mason SJ: Two-dimensional echocardiographic recognition of myocardial injury in man: comparison with postmortem studies. Circulation 1981, 63:401–408.PubMedGoogle Scholar
  10. 10.
    McKay RG, Pfeffer MA, Pasternak RC, et al.: Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. Circulation 1986, 74:693–702.PubMedGoogle Scholar
  11. 11.
    Mitchell GF, Lamas GA, Vaughan DE, Pfeffer MA: Left ventricular remodeling in the year after first anterior myocardial infarction: a quantitative analysis of contractile segment lengths and ventricular shape. J Am Coll Cardiol 1992, 19:1136–1144.PubMedCrossRefGoogle Scholar
  12. 12.
    Erlebacher JA, Weiss JL, Eaton LW, et al.: Late effects of acute infarct dilation on heart size: a two dimensional echocardiographic study. Am J Cardiol 1982, 49:1120–1126.PubMedCrossRefGoogle Scholar
  13. 13.
    Gaudron P, Eilles C, Kugler I, Ertl G: Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors. Circulation 1993, 87:755–763.PubMedGoogle Scholar
  14. 14.
    Picard MH, Wilkins GT, Ray PA, Weyman AE: Natural history of left ventricular size and function after acute myocardial infarction. Assessment and prediction by echocardiographic endocardial surface mapping. Circulation 1990, 82:484–494.PubMedGoogle Scholar
  15. 15.
    Abe M, Kazatani Y, Fukuda H, et al.: Left ventricular volumes, ejection fraction, and regional wall motion calculated with gated technetium-99m tetrofosmin SPECT in reperfused acute myocardial infarction at super-acute phase: comparison with left ventriculography. J Nucl Cardiol 2000, 7:569–574.PubMedCrossRefGoogle Scholar
  16. 16.
    Zellweger MJ, Tabacek G, Zutter AW, et al.: Evidence for left ventricular remodeling after percutaneous coronary intervention: effect of percutaneous coronary intervention on left ventricular ejection fraction and volumes. Int J Cardiol 2004, 96:197–201.PubMedCrossRefGoogle Scholar
  17. 17.
    Rumberger JA, Behrenbeck T, Breen JR, et al.: Nonparallel changes in global left ventricular chamber volume and muscle mass during the first year after transmural myocardial infarction in humans. J Am Coll Cardiol 1993, 21:673–682.PubMedCrossRefGoogle Scholar
  18. 18.
    Bellenger NG, Burgess MI, Ray SG, et al.: Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? Eur Heart J 2000, 21:1387–1396.PubMedCrossRefGoogle Scholar
  19. 19.
    Grothues F, Smith GC, Moon JC, et al.: Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 2002, 90:29–34.PubMedCrossRefGoogle Scholar
  20. 20.
    Grothues F, Moon JC, Bellenger NG, et al.: Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance. Am Heart J 2004, 147:218–223.PubMedCrossRefGoogle Scholar
  21. 21.
    Hammermeister KE, DeRouen TA, Dodge HT: Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations. Circulation 1979, 59:421–430.PubMedGoogle Scholar
  22. 22.
    White HD, Norris RM, Brown MA, et al.: Left ventricular endsystolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987, 76:44–51.PubMedGoogle Scholar
  23. 23.
    Kramer CM, Lima JA, Reichek N, et al.: Regional differences in function within noninfarcted myocardium during left ventricular remodeling. Circulation 1993, 88:1279–1288.PubMedGoogle Scholar
  24. 24.
    Shapiro EP, Rogers WJ, Beyar R, et al.: Determination of left ventricular mass by magnetic resonance imaging in hearts deformed by acute infarction. Circulation 1989, 79:706–711.PubMedGoogle Scholar
  25. 25.
    Konermann M, Sanner BM, Horstmann E, et al.: Changes of the left ventricle after myocardial infarction—estimation with cine magnetic resonance imaging during the first six months. Clin Cardiol 1997, 20:201–212.PubMedCrossRefGoogle Scholar
  26. 26.
    Kramer CM, Rogers WJ, Theobald TM, et al.: Dissociation between changes in intramyocardial function and left ventricular volumes in the eight weeks after first anterior myocardial infarction. J Am Coll Cardiol 1997, 30:1625–1632.PubMedCrossRefGoogle Scholar
  27. 27.
    Matheijssen NA, Baur LH, Reiber JH, et al.: Assessment of left ventricular volume and mass by cine magnetic resonance imaging in patients with anterior myocardial infarction intra-observer and inter-observer variability on contour detection. Int J Card Imaging 1996, 12:11–19.PubMedCrossRefGoogle Scholar
  28. 28.
    Lima JA, Judd RM, Bazille A, et al.: Regional heterogeneity of human myocardial infarcts demonstrated by contrastenhanced MRI. Potential mechanisms. Circulation 1995, 92:1117–1125.PubMedGoogle Scholar
  29. 29.
    Kim RJ, Fieno DS, Parrish TB, et al.: Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999, 100:1992–2002.PubMedGoogle Scholar
  30. 30.
    Simonetti OP, Kim RJ, Fieno DS, et al.: An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001, 218:215–223.PubMedGoogle Scholar
  31. 31.
    Rochitte CE, Lima JA, Bluemke DA, et al.: Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction. Circulation 1998, 98:1006–1014.PubMedGoogle Scholar
  32. 32.
    Wu KC, Kim RJ, Bluemke DA, et al.: Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion. J Am Coll Cardiol 1998, 32:1756–1764.PubMedCrossRefGoogle Scholar
  33. 33.
    Wu KC, Zerhouni EA, Judd RM, et al.: Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998, 97:765–772. This was the first study to demonstrate that the assessment of infarct size and the identification of regions of microvascular obstruction by contrast-enhanced MRI were powerful predictors of long-term outcome after acute MI.PubMedGoogle Scholar
  34. 34.
    Ito H, Maruyama A, Iwakura K, et al.: Clinical implications of the ‘no reflow’ phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996, 93:223–228.PubMedGoogle Scholar
  35. 35.
    Gerber BL, Rochitte CE, Melin JA, et al.: Microvascular obstruction and left ventricular remodeling early after acute myocardial infarction. Circulation 2000, 101:2734–2741. This study used contrast-enhanced MRI to characterize myocardial injury and examine the relationship between different contrastenhancement patterns and LV remodeling after acute MI.PubMedGoogle Scholar
  36. 36.
    Braunwald E, Kloner RA: The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982, 66:1146–1149.PubMedGoogle Scholar
  37. 37.
    Braunwald E, Rutherford JD: Reversible ischemic left ventricular dysfunction: evidence for the "hibernating myocardium." J Am Coll Cardiol 1986, 8:1467–1470.PubMedCrossRefGoogle Scholar
  38. 38.
    Kloner RA, Bolli R, Marban E, et al.: Medical and cellular implications of stunning, hibernation, and preconditioning: an NHLBI workshop. Circulation 1998, 97:1848–1867.PubMedGoogle Scholar
  39. 39.
    Tillisch J, Brunken R, Marshall R, et al.: Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986, 314:884–888.PubMedCrossRefGoogle Scholar
  40. 40.
    Dilsizian V, Rocco TP, Freedman NM, et al.: Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990, 323:141–146.PubMedCrossRefGoogle Scholar
  41. 41.
    Anselmi M, Golia G, Cicoira M, et al.: Prognostic value of detection of myocardial viability using low-dose dobutamine echocardiography in infarcted patients. Am J Cardiol 1998, 81:21G-28G.PubMedCrossRefGoogle Scholar
  42. 42.
    Picano E, Sicari R, Landi P, et al.: Prognostic value of myocardial viability in medically treated patients with global left ventricular dysfunction early after an acute uncomplicated myocardial infarction: a dobutamine stress echocardiographic study. Circulation 1998, 98:1078–1084.PubMedGoogle Scholar
  43. 43.
    Wagner A, Mahrholdt H, Holly TA, et al.: Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 2003, 361:374–379.PubMedCrossRefGoogle Scholar
  44. 44.
    Choi KM, Kim RJ, Gubernikoff G, et al.: Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation 2001, 104:1101–1107.PubMedGoogle Scholar
  45. 45.
    Gerber BL, Garot J, Bluemke DA, et al.: Accuracy of contrastenhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation 2002, 106:1083–1089. This study used tagged MRI to directly quantify regional LV contractility. It demonstrated that the characterization of the infarcted region by contrast-enhanced MRI allowed for the prediction of acute regional functional recovery after MI.PubMedCrossRefGoogle Scholar
  46. 46.
    Kim RJ, Wu E, Rafael A, et al.: The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000, 343:1445–1453. This landmark study demonstrated the ability of contrast-enhanced MRI to evaluate myocardial viability based on assessment of the transmural extent of the infarcted scar in a population with chronic ischemic heart disease.PubMedCrossRefGoogle Scholar
  47. 47.
    Azevedo CF, Amado LC, Kraitchman DL, et al.: The effect of intra-aortic balloon counterpulsation on left ventricular functional recovery early after acute myocardial infarction: a randomized experimental magnetic resonance imaging study. Eur Heart J 2005, 26:1235–1241.PubMedCrossRefGoogle Scholar
  48. 48.
    Gerber BL, Rochitte CE, Bluemke DA, et al.: Relation between Gd-DTPA contrast enhancement and regional inotropic response in the periphery and center of myocardial infarction. Circulation 2001, 104:998–1004.PubMedGoogle Scholar
  49. 49.
    Azevedo CF, Amado LC, Kraitchman DL, et al.: Persistent diastolic dysfunction despite complete systolic functional recovery after reperfused acute myocardial infarction demonstrated by tagged magnetic resonance imaging. Eur Heart J 2004, 25:1419–1427.PubMedCrossRefGoogle Scholar
  50. 50.
    Ichikawa Y, Sakuma H, Suzawa N, et al.: Late gadoliniumenhanced magnetic resonance imaging in acute and chronic myocardial infarction. Improved prediction of regional myocardial contraction in the chronic state by measuring thickness of nonenhanced myocardium. J Am Coll Cardiol 2005, 45:901–909.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2005

Authors and Affiliations

  • Clerio F. Azevedo
    • 1
  • Susan Cheng
    • 1
  • João A. C. Lima
    • 1
  1. 1.Division of Cardiology, Blalock 524Johns Hopkins University School of MedicineBaltimoreUSA

Personalised recommendations